Breaking News Instant updates and real-time market news.

NEXT

NextDecade

$4.62 /

+0.205 (+4.65%)

08:17
07/06/22
07/06
08:17
07/06/22
08:17

NextDecade executes 20-year SPA with Guangdong Energy

NextDecade announced the execution of a 20-year sale and purchase agreement, or SPA, with Guangdong Energy Group for the supply of liquefied natural gas, or LNG, from NextDecade's Rio Grande LNG export project, or RGLNG, in Brownsville, Texas. The SPA was completed pursuant to the Binding Heads of Agreement previously announced on March 24. Under the SPA, Guangdong Energy Group will purchase approximately 1M tons per annum, or MTPA, of LNG indexed to Henry Hub and delivered on an ex-ship, or DES, basis. The LNG will be supplied from Rio Grande LNG Train 1, which is expected to start commercial operations as early as 2026. Guangdong Energy Group has the right to purchase an additional 0.5 MTPA of LNG from RGLNG. Based on current expected demand for LNG and assuming the achievement of further LNG contracting and financing, NextDecade anticipates making a positive final investment decision on up to three trains of the Rio Grande LNG export project in the second half of 2022, with FIDs of its remaining trains to follow thereafter.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Pear Therapeutics price target lowered to $9 from $13 at Chardan » 07:48
08/12/22
08/12
07:48
08/12/22
07:48
PEAR

Pear Therapeutics

$2.25 /

+0.27 (+13.64%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
05/17/22 Chardan
Pear Therapeutics price target lowered to $13 from $16 at Chardan
05/17/22 Citi
Pear Therapeutics price target raised to $11 from $10 at Citi
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

Recommendations
Laird Superfood price target lowered to $5 from $6 at Canaccord » 07:46
08/12/22
08/12
07:46
08/12/22
07:46
LSF

Laird Superfood

$1.99 /

-0.145 (-6.79%)

Canaccord analyst Bobby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

05/13/22 Craig-Hallum
Laird Superfood price target lowered to $6 from $12 at Craig-Hallum
03/09/22 Craig-Hallum
Laird Superfood price target lowered to $12 from $20 at Craig-Hallum
03/09/22 Canaccord
Laird Superfood price target lowered to $12 from $17 at Canaccord
02/01/22 Craig-Hallum
Laird Superfood price target lowered to $20 from $40 at Craig-Hallum
LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

Recommendations
Solo Brands price target lowered to $11 from $14 at Credit Suisse » 07:46
08/12/22
08/12
07:46
08/12/22
07:46
DTC

Solo Brands

$5.98 /

-0.01 (-0.17%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTC Solo Brands
$5.98 /

-0.01 (-0.17%)

DTC Solo Brands
$5.98 /

-0.01 (-0.17%)

08/02/22 Citi
Solo Brands transferred with Buy rating at Citi
05/13/22 Citi
Solo Brands price target lowered to $11 from $16 at Citi
03/30/22 Citi
Solo Brands price target lowered to $16 from $20 at Citi
01/11/22 Citi
Solo Brands upgraded to Buy from Neutral at Citi
DTC Solo Brands
$5.98 /

-0.01 (-0.17%)

  • 28
    Oct
DTC Solo Brands
$5.98 /

-0.01 (-0.17%)

DTC Solo Brands
$5.98 /

-0.01 (-0.17%)

Periodicals
Regulators raised doubts about Cheniere's turbines years ago, Reuters reports » 07:45
08/12/22
08/12
07:45
08/12/22
07:45
LNG

Cheniere Energy

$154.67 /

+3.97 (+2.63%)

U.S. regulators raised…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

08/05/22 Mizuho
Cheniere Energy price target raised to $167 from $159 at Mizuho
05/31/22 Wells Fargo
Wells Fargo downgrades Cheniere Energy Partners to Underweight on valuation
05/23/22 RBC Capital
Cheniere Energy price target raised to $178 from $151 at RBC Capital
05/12/22 JPMorgan
Cheniere Energy price target raised to $192 from $183 at JPMorgan
LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

LNG Cheniere Energy
$154.67 /

+3.97 (+2.63%)

Downgrade
CS Disco downgraded to Hold at Canaccord as estimates get reset » 07:45
08/12/22
08/12
07:45
08/12/22
07:45
LAW

CS Disco

$28.96 /

+0.39 (+1.37%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

07:15 Today Stifel
CS Disco price target lowered to $30 from $40 at Stifel
06:15 Today BofA
CS Disco downgraded to Neutral from Buy at BofA
06:05 Today Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
05:40 Today Cowen
Cowen cuts CS Disco to Market Perform as momentum hits 'big snag'
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

  • 15
    Sep
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

Recommendations
Illumina price target lowered to $380 from $450 at Canaccord » 07:44
08/12/22
08/12
07:44
08/12/22
07:44
ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

Canaccord analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

07:16 Today Stifel
Illumina price target lowered to $300 from $480 at Stifel
06:59 Today Citi
Illumina price target lowered to $200 from $220 at Citi
06:36 Today Baird
Illumina price target lowered to $215 from $306 at Baird
08/11/22 Piper Sandler
Illumina miss 'surprising' given backlog, says Piper Sandler
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

Recommendations
Six Flags price target lowered to $20 from $32 at Truist » 07:44
08/12/22
08/12
07:44
08/12/22
07:44
SIX

Six Flags

$21.12 /

-4.685 (-18.16%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

07:18 Today Stifel
Six Flags price target lowered to $28 from $35 at Stifel
05:44 Today KeyBanc
Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2
08/11/22 KeyBanc
Six Flags downgraded to Sector Weight from Overweight at KeyBanc
07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
SIX Six Flags
$21.12 /

-4.685 (-18.16%)

SIX Six Flags
$21.12 /

-4.685 (-18.16%)

Recommendations
Xos price target lowered to $5 from $11 at DA Davidson » 07:42
08/12/22
08/12
07:42
08/12/22
07:42
XOS

Xos

$1.99 /

-0.09 (-4.33%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOS Xos
$1.99 /

-0.09 (-4.33%)

XOS Xos
$1.99 /

-0.09 (-4.33%)

07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
06/03/22 Northland
Xos initiated with an Outperform at Northland
12/08/21 BofA
Xos initiated with an Underperform at BofA
12/02/21 Goldman Sachs
Xos initiated with a Neutral at Goldman Sachs
XOS Xos
$1.99 /

-0.09 (-4.33%)

XOS Xos
$1.99 /

-0.09 (-4.33%)

Recommendations
Privia Health price target raised to $44 from $35 at Cowen » 07:41
08/12/22
08/12
07:41
08/12/22
07:41
PRVA

Privia Health

$37.81 /

+1.42 (+3.90%)

Cowen analyst Gary Taylor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

07/14/22 Truist
Privia Health price target raised to $40 from $36 at Truist
06/29/22 Canaccord
Privia Health price target raised to $40 from $29 at Canaccord
05/13/22 Canaccord
Privia Health price target lowered to $29 from $44 at Canaccord
05/03/22 BofA
BofA starts Privia Health at Buy as value-based care play
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

  • 19
    Nov
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

Recommendations
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan » 07:40
08/12/22
08/12
07:40
08/12/22
07:40
SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

, GSK

GSK plc

$35.75 /

-2.57 (-6.71%)

, HLN

Haleon

$6.29 /

-0.22 (-3.38%)

, PFE

Pfizer

$48.31 /

-1.62 (-3.24%)

JPMorgan analysts Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

05:33 Today Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
GSK GSK plc
$35.75 /

-2.57 (-6.71%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
HLN Haleon
$6.29 /

-0.22 (-3.38%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
07/25/22 Goldman Sachs
Haleon initiated with a Buy at Goldman Sachs (last week)
PFE Pfizer
$48.31 /

-1.62 (-3.24%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

Recommendations
ForgeRock price target lowered to $25 from $28 at Cowen » 07:39
08/12/22
08/12
07:39
08/12/22
07:39
FORG

ForgeRock

$22.24 /

-1.13 (-4.84%)

Cowen analyst Shaul Eyal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

07/13/22 Piper Sandler
ForgeRock price target raised to $25 from $24 at Piper Sandler
06/22/22 JPMorgan
ForgeRock price target lowered to $30 from $36 at JPMorgan
05/12/22 Deutsche Bank
ForgeRock price target lowered to $15 from $16 at Deutsche Bank
05/12/22 Mizuho
ForgeRock price target lowered to $24 from $32 at Mizuho
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

  • 16
    Sep
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

Recommendations
Cellebrite price target lowered to $10 from $13 at Cowen » 07:38
08/12/22
08/12
07:38
08/12/22
07:38
CLBT

Cellebrite

$5.28 /

-0.4 (-7.04%)

Cowen analyst Shaul Eyal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

07:14 Today William Blair
Cellebrite downgraded to Market Perform at William Blair after guidance cut
06:06 Today William Blair
Cellebrite downgraded to Market Perform from Outperform at William Blair
05/16/22 Cowen
Cellebrite price target lowered to $13 from $17 at Cowen
05/13/22 Deutsche Bank
Cellebrite price target lowered to $10 from $11 at Deutsche Bank
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

Recommendations
LegalZoom price target lowered to $19 from $24 at Credit Suisse » 07:38
08/12/22
08/12
07:38
08/12/22
07:38
LZ

LegalZoom

$11.11 /

-0.175 (-1.55%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight on estimate risk at Morgan Stanley
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Morgan Stanley
LegalZoom price target lowered to $12 from $13 at Morgan Stanley
04/19/22 Citi
LegalZoom assumed with Buy from Neutral at Citi
LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

Recommendations
Rockley Photonics price target lowered to $14 from $21 at Cowen » 07:37
08/12/22
08/12
07:37
08/12/22
07:37
RKLY

Rockley Photonics

$2.00 /

-0.1 (-4.76%)

Cowen analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

06:37 Today Baird
Rockley Photonics downgraded to Neutral from Outperform at Baird
06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/13/22 Needham
Rockley Photonics price target lowered to $4 from $8 at Needham
RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

Earnings
Axcella Health reports Q2 EPS (40c), consensus (38c) » 07:37
08/12/22
08/12
07:37
08/12/22
07:37
AXLA

Axcella Health

$2.34 /

+ (+0.00%)

As of June 30, cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXLA Axcella Health
$2.34 /

+ (+0.00%)

AXLA Axcella Health
$2.34 /

+ (+0.00%)

08/03/22 H.C. Wainwright
Axcella Health price target lowered to $8 from $14 at H.C. Wainwright
05/09/22 Chardan
Axcella Health price target lowered to $7 from $12 at Chardan
10/12/21 Noble Capital
Axcella Health initiated with an Outperform at Noble Capital
09/22/21 Goldman Sachs
Axcella Health downgraded to Neutral from Buy at Goldman Sachs
AXLA Axcella Health
$2.34 /

+ (+0.00%)

Recommendations
Kore Group price target lowered to $9 from $12.50 at Cowen » 07:35
08/12/22
08/12
07:35
08/12/22
07:35
KORE

Kore Group

$2.71 /

-0.03 (-1.09%)

Cowen analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KORE Kore Group
$2.71 /

-0.03 (-1.09%)

KORE Kore Group
$2.71 /

-0.03 (-1.09%)

05/17/22 Deutsche Bank
Kore Group price target lowered to $6 from $7.50 at Deutsche Bank
04/12/22 Morgan Stanley
Kore Group price target lowered to $6.50 from $7.50 at Morgan Stanley
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
03/10/22 Cowen
Kore Group price target lowered to $12.50 from $18 at Cowen
KORE Kore Group
$2.71 /

-0.03 (-1.09%)

KORE Kore Group
$2.71 /

-0.03 (-1.09%)

Earnings
Soligenix reports Q2 EPS (6c), consensus (8c) » 07:34
08/12/22
08/12
07:34
08/12/22
07:34
SNGX

Soligenix

/

+

Reports Q2 revenue $0.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNGX Soligenix
/

+

SNGX Soligenix
/

+

08/25/21 Alliance Global Partners
Soligenix price target lowered to $3.75 from $5.75 at Alliance Global Partners
Hot Stocks
Marathon Gold reports Q2 capex C$9.2M vs. C$4.7M last year » 07:33
08/12/22
08/12
07:33
08/12/22
07:33
MGDPF

Marathon Gold

$1.55 /

-0.007 (-0.45%)

Matt Manson, President,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

07/21/22 National Bank
Marathon Gold price target lowered to C$2.50 from C$3.75 at National Bank
07/07/22 Canaccord
Marathon Gold price target lowered to C$3.50 from C$3.60 at Canaccord
06/14/22 RBC Capital
Marathon Gold price target lowered to C$3.50 from C$4 at RBC Capital
05/16/22 TD Securities
Marathon Gold price target lowered to C$3.50 from C$4 at TD Securities
MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

Recommendations
Taysha Gene Therapies price target lowered to $5 from $9 at Wedbush » 07:33
08/12/22
08/12
07:33
08/12/22
07:33
TSHA

Taysha Gene Therapies

$3.96 /

-0.95 (-19.35%)

Wedbush analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

05/17/22 Chardan
Taysha Gene Therapies price target lowered to $34 from $37 at Chardan
04/01/22 Truist
Taysha Gene Therapies price target lowered to $35 from $60 at Truist
03/31/22 Chardan
Taysha Gene Therapies price target lowered to $37 from $60 at Chardan
03/09/22 Baird
Baird expects positive GAN guide for Taysha Gene Therapies, starts at Outperform
TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

Recommendations
Fastly price target lowered to $25 from $35 at Raymond James » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
FSLY

Fastly

$11.56 /

-0.275 (-2.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

08/04/22 Craig-Hallum
Fastly price target lowered to $13 from $19 at Craig-Hallum
07/22/22 Citi
Fastly price target lowered to $10 from $14 at Citi
07/19/22 RBC Capital
Fastly downgraded to Underperform from Sector Perform at RBC Capital
07/19/22 RBC Capital
Fastly downgraded to Underperform from Sector Perform at RBC Capital
FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

Recommendations
Leafly price target lowered to $4 from $12 at Cowen » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
LFLY

Leafly

$2.25 /

-0.15 (-6.25%)

Cowen analyst Harrison…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

06:12 Today Benchmark
Leafly price target lowered to $6.50 from $12.00 at Benchmark
05/20/22 Cowen
Cowen starts Leafly with Outperform with its early mover advantage
05/20/22 Cowen
Leafly initiated with an Outperform at Cowen
05/18/22 Oppenheimer
Leafly initiated with a Perform at Oppenheimer
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

Downgrade
Sally Beauty downgraded to Market Perform at Cowen on risk to FY23 estimates » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
SBH

Sally Beauty

$15.20 /

+0.66 (+4.54%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

05:56 Today Cowen
Sally Beauty downgraded to Market Perform from Outperform at Cowen
06/29/22 Raymond James
Raymond James cuts Sally Beauty to Underperform on exposure low-income consumer
06/29/22 Raymond James
Sally Beauty downgraded to Underperform from Market Perform at Raymond James
06/16/22 Morgan Stanley
Sally Beauty downgraded to Underweight from Equal Weight at Morgan Stanley
SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

Downgrade
PagerDuty downgraded to Neutral from Buy at Monness Crespi » 07:31
08/12/22
08/12
07:31
08/12/22
07:31
PD

PagerDuty

$28.13 /

-1.145 (-3.91%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

07/07/22 Canaccord
PagerDuty initiated with a Buy at Canaccord
06/03/22 Craig-Hallum
PagerDuty price target lowered to $37 from $45 at Craig-Hallum
06/03/22 Baird
PagerDuty price target lowered to $40 from $47 at Baird
05/31/22 RBC Capital
PagerDuty price target lowered to $41 from $46 at RBC Capital
PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

Downgrade
TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:30
08/12/22
08/12
07:30
08/12/22
07:30
TRSSF

TerrAscend

$2.40 /

+0.11 (+4.80%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

07/22/22 Seaport Global
TerrAscend initiated with a Buy at Seaport Global
02/09/22 Clarus
TerrAscend price target lowered to C$14 from C$16.25 at Clarus
12/08/21 Cantor Fitzgerald
TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald
11/17/21 Stifel
TerrAscend price target lowered to C$21 from C$23 at Stifel
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

Downgrade
NextNav cut to Perform at Oppenheimer on capital needs » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
NN

NextNav

$3.39 /

+0.02 (+0.59%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NN NextNav
$3.39 /

+0.02 (+0.59%)

NN NextNav
$3.39 /

+0.02 (+0.59%)

06:32 Today Oppenheimer
NextNav downgraded to Perform from Outperform at Oppenheimer
05/16/22 R.F. Lafferty
NextNav price target lowered to $15 from $16 at R.F. Lafferty
05/13/22 B. Riley
NextNav price target lowered to $14.25 from $17 at B. Riley
01/06/22 R.F. Lafferty
NextNav initiated with a Buy at R.F. Lafferty
NN NextNav
$3.39 /

+0.02 (+0.59%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.